AgersoHSeiding LarsenLRiisALovgrenUKarlssonMOSenderovitzTPharmacokinetics and renal excretion of desmopressin after intravenous administration to healthy subjects and renally impaired patientsBr J Clin Pharmacol2004584352–358188460410.1111/j.1365-2125.2004.02175.x
2.
BerntorpEPeakeIBuddeUVon willebrand's disease: A report from a meeting in the aland islandsHaemophilia.201218Suppl 61–13417087610.1111/j.1365-2516.2012.02925.x
3.
CastamanGFedericiABRodeghieroFMannucciPMVon willebrand's disease in the year 2003: Towards the complete identification of gene defects for correct diagnosis and treatmentHaematologica200388194–108
4.
FavaloroEJBodoIIsraelsSJBrownSAVon willebrand disease and platelet disordersHaemophilia.201420Suppl 459–6410.1111/hae.12414
5.
RodenburgEMHoornEJRuiterRThiazide-associated hyponatremia: A population-based studyAm J Kidney Dis201362167–7210.1053/j.ajkd.2013.02.365
6.
SharmaRSteinDHyponatremia after desmopressin (DDAVP) use in pediatric patients with bleeding disorders undergoing surgeriesJ Pediatr Hematol Oncol2014366e371–510.1097/MPH.0000000000000185
7.
StoneMEMazzeffiMDerhamJKorshinACurrent management of von willebrand disease and von willebrand syndromeCurr Opin Anaesthesiol2014273353–35810.1097/ACO.0000000000000083
8.
VerruaEMantovaniGFerranteESevere water intoxication secondary to the concomitant intake of non-steroidal anti-inflammatory drugs and desmopressin: A case report and review of the literatureHormones (Athens)2013121135–141
